Publications by authors named "Russell Wiesner"

Claim this Profile
A
Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
Anan Abu Rmilah, Robert Fencl, Kymberly Watt, Michael Krowka, Russell Wiesner

Transplantation· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection.
Caroline C Jadlowiec, Paige E Morgan, Avinash K Nehra, Matthew A Hathcock, Walter K Kremers, Russell H Wiesner

Liver Transpl· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heavy Alcohol Use Among Deceased Donors Does Not Impact Recipient Outcomes After Liver Transplantation.
Sumant S Arora, Khushdeep S Chahal, Page Axley, Devin E Eckhoff, Yong-Fang Kuo, Russell Wiesner

Transplantation· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MELD Stratified Outcomes Among Recipients With Diabetes or Hypertension: Simultaneous Liver Kidney Versus Liver Alone.
Ashwani K Singal, Mohsen Hasanin, Mohamed Kaif, Russell W Wiesner, Yong-Fang Kuo

J Clin Gastroenterol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
Mohamad A Mouchli, Siddharth Singh, Edward V Loftus, Lisa Boardman, Jayant Talwalkar, Russell H Wiesner

Transplantation· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease.
Wonngarm Kittanamongkolchai, Ziad M El-Zoghby, J Eileen Hay, Russell H Wiesner, Patrick S Kamath

Hepatol Int· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation.
Ashwani K Singal, Xiao Fang, Mohamed Kaif, Mohsen Hasanin, Brendan M Mcguire, Russell H Wiesner

Transpl Int· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
Ju Dong Yang, Joseph J Larson, Kymberly D Watt, Alina M Allen, Russell H Wiesner

Clin Gastroenterol Hepatol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients with Liver Cirrhosis.
Hager A Ahmed Mohammed, Ju Dong Yang, Nasra H Giama, Jonggi Choi, Hawa M Ali, Russell H Wiesner

Liver Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.
Amanda M Lynn, Siddharth Singh, Stephen E Congly, Disha Khemani, David H Johnson, Russell H Wiesner

Liver Transpl· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Liver Failure Prognostic Scores: Is Good Enough Good Enough?
Patrick S Kamath, Julie Heimbach, Russell H Wiesner

Clin Gastroenterol Hepatol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
Ashwani Kumar Singal, Mohsen Hasanin, Mohamed Kaif, Russell Wiesner, Yong-Fang Kuo

Transplantation· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.
Renumathy Dhanasekaran, William Sanchez, Taofic Mounajjed, Russell H Wiesner, Kymberly D Watt

Liver Int· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In a rapidly changing world, can we truly predict the impact of liver graft quality 15 years from now?
Russell H Wiesner

Liver Transpl· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of liver transplantation alone after listing for simultaneous kidney: comparison to simultaneous liver kidney transplantation.
Bashar Hmoud, Yong-Fang Kuo, Russell H Wiesner, Ashwani K Singal

Transplantation· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving trends in liver transplantation: listing and liver donor allocation.
Russell H Wiesner

Clin Liver Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology.
Ashwani K Singal, Habeeb Salameh, Yong-Fang Kuo, Russell H Wiesner

Transplantation· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.
Michael J Krowka, Russell H Wiesner, Julie K Heimbach

J Hepatol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatopulmonary syndrome: favorable outcomes in the MELD exception era.
Vivek N Iyer, Karen L Swanson, Rodrigo Cartin-Ceba, Ross A Dierkhising, Charles B Rosen, Russell H Wiesner

Hepatology· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.
Ashwani K Singal, Praveen Guturu, Bashar Hmoud, Yong-Fang Kuo, Habeeb Salameh, Russell H Wiesner

Transplantation· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving toward evidence-based liver allocation in patients with primary sclerosing cholangitis.
Russell H Wiesner

Liver Transpl· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulating therapy in liver transplantation: principles and practice.
Jody C Olson, Russell H Wiesner

Immunotherapy· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.
Stepan Sembera, Craig Lammert, Jayant A Talwalkar, Schuyler O Sanderson, John J Poterucha, Russell H Wiesner

Liver Transpl· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we change the priority for liver allocation for patients with the highest MELD score?
Richard B Freeman, Russell Wiesner

Hepatology· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Present state of immunosuppressive therapy in liver transplant recipients.
Russell H Wiesner, John J Fung

Liver Transpl· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis